| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| APRE | Aprea Therapeutics, Inc. | SCHADE CHRISTIAN S | Chairman & CEO | Jun 03, 2022 | Option Exercise | $0.81 | 65,770 | 52,945 | 226,846 | Jun 07, 2022, 05:05 PM | |
| APRE | Aprea Therapeutics, Inc. | SCHADE CHRISTIAN S | Chairman & CEO | May 18, 2022 | Buy | $0.64 | 37,500 | 24,124 | 292,616 | May 19, 2022, 04:30 PM | |
| APRE | Aprea Therapeutics, Inc. | SCHADE CHRISTIAN S | Chairman & CEO | Feb 25, 2022 | Option Exercise | $1.74 | 21,644 | 37,661 | 155,016 | Mar 01, 2022, 05:02 PM | |
| APRE | Aprea Therapeutics, Inc. | SCHADE CHRISTIAN S | President & CEO | Oct 07, 2019 | Buy | $15.00 | 6,000 | 90,000 | 1,000 | Oct 07, 2019, 07:15 PM | |
| APRE | Aprea Therapeutics, Inc. | SCHADE CHRISTIAN S | President & CEO | Oct 07, 2019 | Buy | $15.00 | 5,000 | 75,000 | 5,000 | Oct 07, 2019, 07:15 PM | |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | SCHADE CHRISTIAN S | Director | May 10, 2019 | Sale | $36.76 | 31,316 | 1,151,256 | 48,291 | May 14, 2019, 04:19 PM | |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | SCHADE CHRISTIAN S | Director | Mar 05, 2018 | Sale | $35.47 | 31,316 | 1,110,771 | 45,326 | Mar 06, 2018, 04:17 PM | |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | SCHADE CHRISTIAN S | Director | May 03, 2016 | Sale | $55.81 | 15,658 | 873,944 | 18,550 | May 05, 2016, 04:12 PM | |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | SCHADE CHRISTIAN S | Director | Feb 28, 2014 | Sale | $35.94 | 15,000 | 539,072 | 19,402 | Feb 28, 2014, 05:23 PM | |
| OMTH | Omthera Pharmaceuticals, Inc. | SCHADE CHRISTIAN S | Executive VP and CFO | Jul 16, 2013 | Option Exercise | $2.08 | 316,292 | 657,887 | 341,893 | Jul 18, 2013, 01:47 PM | |
| NRG | NRG ENERGY, INC. | SCHADE CHRISTIAN S | Exec VP & Chief Financial Ofc | Mar 29, 2011 | Option Exercise | $21.60 | 4,884 | 105,494 | 34,916 | Mar 30, 2011, 04:29 PM |
Menu